Please enable JavaScript to continue using this application.

Compare $LEGN vs $VCYT | Chartloom

Compare

$LEGN vs $VCYT

Legend Biotech Corp · Veracyte Inc

LEGN

Legend Biotech Corp

VCYT

Veracyte Inc

Compare $LEGN vs $VCYT

Comparing Legend Biotech Corp and Veracyte Inc

LEGNLegend Biotech Corp

VCYTVeracyte Inc

LEGNLegend Biotech Corp

Market cap

$3.62B

P/E (TTM)

—

Forward P/E (NTM)

25.42x

Forward P/S (NTM)

2.17x

Rev growth (TTM)

59.6%

YTD performance

-13.4%

52W performance

-42.2%

FCF yield

-3.4%

VCYTVeracyte Inc

Market cap

$3.61B

P/E (TTM)

32.42x

Forward P/E (NTM)

24.66x

Forward P/S (NTM)

5.69x

Rev growth (TTM)

17.3%

YTD performance

6.7%

52W performance

28.9%

FCF yield

4.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

LEGN

VCYT

Detailed metrics comparison

LEGN

Legend Biotech Corp

VCYT

Veracyte Inc

Market Cap

LEGN$3.62B

VCYT$3.61B

Enterprise Value

LEGN$3.23B

VCYT$3.31B

Price

LEGN$18.62

VCYT$45.23

P/E Ratio

LEGNN/A

VCYT32.42x

P/S Ratio

LEGN2.85x

VCYT6.42x

EV/Sales

LEGN2.54x

VCYT5.89x

EV/EBITDA

LEGN0.00x

VCYT24.67x

P/B Ratio

LEGN3.04x

VCYT2.65x

P/FCF Ratio

LEGNN/A

VCYT21.74x

EV/FCF

LEGN-26.50x

VCYT19.94x

PEG Ratio

LEGNN/A

VCYT0.10x

Forward P/E (NTM)

LEGN25.42x

VCYT24.66x

Forward P/S (NTM)

LEGN2.17x

VCYT5.69x

Revenue (TTM)

LEGN$1.27B

VCYT$562M

Revenue Growth (YoY)

LEGN59.6%

VCYT17.3%

Forward Rev Growth

LEGN25.0%

VCYT11.4%

Gross Margin (TTM)

LEGN56.6%

VCYT71.7%

Operating Margin (TTM)

LEGN0.0%

VCYT19.6%

EBITDA Margin (TTM)

LEGN-0.8%

VCYT22.5%

Net Margin (TTM)

LEGN-7.2%

VCYT20.4%

FCF Margin (TTM)

LEGN-9.6%

VCYT29.5%

Net Income (TTM)

LEGN$-92M

VCYT$114M

FCF (TTM)

LEGN$-122M

VCYT$166M

EPS (TTM)

LEGN-$0.47

VCYT$1.40

ROE (TTM)

LEGN-870.0%

VCYT8.6%

ROA (TTM)

LEGN-539.0%

VCYT8.0%

ROIC (TTM)

LEGN-643.0%

VCYT8.6%

Cash

LEGN$673M

VCYT$300M

Debt

LEGN$278M

VCYT$0

Net Cash/Debt

LEGN$395M

VCYT$300M

Current Ratio (TTM)

LEGN3.04x

VCYT9.16x

Quick Ratio (TTM)

LEGN2.89x

VCYT8.60x

Debt/Equity (TTM)

LEGN0.23x

VCYT0.00x

Debt/Assets (TTM)

LEGN0.0%

VCYT0.0%

Interest Coverage (TTM)

LEGNN/A

VCYTN/A

Net Debt/EBITDA (TTM)

LEGN0.00x

VCYT0.00x

Beta

LEGN0.57

VCYT2.00

52W Performance

LEGN-42.2%

VCYT28.9%

YTD Performance

LEGN-13.4%

VCYT6.7%

% from 52W High

LEGN-50.3%

VCYT-25.7%

% from 52W Low

LEGN14.7%

VCYT53.6%

Asset Turnover (TTM)

LEGN0.75x

VCYT0.39x

FCF Yield (TTM)

LEGN-3.4%

VCYT4.6%

Earnings Yield (TTM)

LEGN-2.5%

VCYT3.2%

Dividend Yield (TTM)

LEGNN/A

VCYTN/A

Rule of 40

LEGN50.0

VCYT46.8

EV/GP/RG

LEGN0.13

VCYT0.60

Ticker research

View LEGN research View VCYT research

Metric	LEGN Legend Biotech Corp	VCYT Veracyte Inc
Market & Valuation
Market Cap	$3.62B	$3.61B
Enterprise Value	$3.23B	$3.31B
Price	$18.62	$45.23
P/E Ratio	N/A	32.42x
P/S Ratio	2.85x	6.42x
EV/Sales	2.54x	5.89x
EV/EBITDA	0.00x	24.67x
P/B Ratio	3.04x	2.65x
P/FCF Ratio	N/A	21.74x
EV/FCF	-26.50x	19.94x
PEG Ratio	N/A	0.10x
Forward P/E (NTM)	25.42x	24.66x
Forward P/S (NTM)	2.17x	5.69x
Revenue & Growth
Revenue (TTM)	$1.27B	$562M
Revenue Growth (YoY)	59.6%	17.3%
Forward Rev Growth	25.0%	11.4%
Profitability
Gross Margin (TTM)	56.6%	71.7%
Operating Margin (TTM)	0.0%	19.6%
EBITDA Margin (TTM)	-0.8%	22.5%
Net Margin (TTM)	-7.2%	20.4%
FCF Margin (TTM)	-9.6%	29.5%
Net Income (TTM)	$-92M	$114M
FCF (TTM)	$-122M	$166M
EPS (TTM)	-$0.47	$1.40
ROE (TTM)	-870.0%	8.6%
ROA (TTM)	-539.0%	8.0%
ROIC (TTM)	-643.0%	8.6%
Financial Health
Cash	$673M	$300M
Debt	$278M	$0
Net Cash/Debt	$395M	$300M
Current Ratio (TTM)	3.04x	9.16x
Quick Ratio (TTM)	2.89x	8.60x
Debt/Equity (TTM)	0.23x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.57	2.00
52W Performance	-42.2%	28.9%
YTD Performance	-13.4%	6.7%
% from 52W High	-50.3%	-25.7%
% from 52W Low	14.7%	53.6%
Efficiency & Yields
Asset Turnover (TTM)	0.75x	0.39x
FCF Yield (TTM)	-3.4%	4.6%
Earnings Yield (TTM)	-2.5%	3.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	50.0	46.8
EV/GP/RG	0.13	0.60
Ticker research	View LEGN research	View VCYT research

Valuation

P/E Ratio

VCYT

32.42x

P/S Ratio

LEGN

2.85x

VCYT

6.42x

EV/FCF

LEGN

-26.50x

VCYT

19.94x

Growth & revenue

Revenue Growth TTM

LEGN

59.6%

VCYT

17.3%

Forward Revenue Growth

LEGN

25.0%

VCYT

11.4%

Profitability & performance

Gross Margin

VCYT

71.7%

LEGN

56.6%

ROE

VCYT

8.6%

LEGN

-870.0%

FCF Yield %

VCYT

4.6%

LEGN

-3.4%

52-Week Performance

VCYT

28.9%

LEGN

-42.2%

Detailed metrics comparison

LEGN

Legend Biotech Corp

VCYT

Veracyte Inc

Market Cap

LEGN$3.62B

VCYT$3.61B

Enterprise Value

LEGN$3.23B

VCYT$3.31B

Price

LEGN$18.62

VCYT$45.23

P/E Ratio

LEGNN/A

VCYT32.42x

P/S Ratio

LEGN2.85x

VCYT6.42x

EV/Sales

LEGN2.54x

VCYT5.89x

EV/EBITDA

LEGN0.00x

VCYT24.67x

P/B Ratio

LEGN3.04x

VCYT2.65x

P/FCF Ratio

LEGNN/A

VCYT21.74x

EV/FCF

LEGN-26.50x

VCYT19.94x

PEG Ratio

LEGNN/A

VCYT0.10x

Forward P/E (NTM)

LEGN25.42x

VCYT24.66x

Forward P/S (NTM)

LEGN2.17x

VCYT5.69x

Revenue (TTM)

LEGN$1.27B

VCYT$562M

Revenue Growth (YoY)

LEGN59.6%

VCYT17.3%

Forward Rev Growth

LEGN25.0%

VCYT11.4%

Gross Margin (TTM)

LEGN56.6%

VCYT71.7%

Operating Margin (TTM)

LEGN0.0%

VCYT19.6%

EBITDA Margin (TTM)

LEGN-0.8%

VCYT22.5%

Net Margin (TTM)

LEGN-7.2%

VCYT20.4%

FCF Margin (TTM)

LEGN-9.6%

VCYT29.5%

Net Income (TTM)

LEGN$-92M

VCYT$114M

FCF (TTM)

LEGN$-122M

VCYT$166M

EPS (TTM)

LEGN-$0.47

VCYT$1.40

ROE (TTM)

LEGN-870.0%

VCYT8.6%

ROA (TTM)

LEGN-539.0%

VCYT8.0%

ROIC (TTM)

LEGN-643.0%

VCYT8.6%

Cash

LEGN$673M

VCYT$300M

Debt

LEGN$278M

VCYT$0

Net Cash/Debt

LEGN$395M

VCYT$300M

Current Ratio (TTM)

LEGN3.04x

VCYT9.16x

Quick Ratio (TTM)

LEGN2.89x

VCYT8.60x

Debt/Equity (TTM)

LEGN0.23x

VCYT0.00x

Debt/Assets (TTM)

LEGN0.0%

VCYT0.0%

Interest Coverage (TTM)

LEGNN/A

VCYTN/A

Net Debt/EBITDA (TTM)

LEGN0.00x

VCYT0.00x

Beta

LEGN0.57

VCYT2.00

52W Performance

LEGN-42.2%

VCYT28.9%

YTD Performance

LEGN-13.4%

VCYT6.7%

% from 52W High

LEGN-50.3%

VCYT-25.7%

% from 52W Low

LEGN14.7%

VCYT53.6%

Asset Turnover (TTM)

LEGN0.75x

VCYT0.39x

FCF Yield (TTM)

LEGN-3.4%

VCYT4.6%

Earnings Yield (TTM)

LEGN-2.5%

VCYT3.2%

Dividend Yield (TTM)

LEGNN/A

VCYTN/A

Rule of 40

LEGN50.0

VCYT46.8

EV/GP/RG

LEGN0.13

VCYT0.60

Ticker research

View LEGN research View VCYT research

Metric	LEGN Legend Biotech Corp	VCYT Veracyte Inc
Market & Valuation
Market Cap	$3.62B	$3.61B
Enterprise Value	$3.23B	$3.31B
Price	$18.62	$45.23
P/E Ratio	N/A	32.42x
P/S Ratio	2.85x	6.42x
EV/Sales	2.54x	5.89x
EV/EBITDA	0.00x	24.67x
P/B Ratio	3.04x	2.65x
P/FCF Ratio	N/A	21.74x
EV/FCF	-26.50x	19.94x
PEG Ratio	N/A	0.10x
Forward P/E (NTM)	25.42x	24.66x
Forward P/S (NTM)	2.17x	5.69x
Revenue & Growth
Revenue (TTM)	$1.27B	$562M
Revenue Growth (YoY)	59.6%	17.3%
Forward Rev Growth	25.0%	11.4%
Profitability
Gross Margin (TTM)	56.6%	71.7%
Operating Margin (TTM)	0.0%	19.6%
EBITDA Margin (TTM)	-0.8%	22.5%
Net Margin (TTM)	-7.2%	20.4%
FCF Margin (TTM)	-9.6%	29.5%
Net Income (TTM)	$-92M	$114M
FCF (TTM)	$-122M	$166M
EPS (TTM)	-$0.47	$1.40
ROE (TTM)	-870.0%	8.6%
ROA (TTM)	-539.0%	8.0%
ROIC (TTM)	-643.0%	8.6%
Financial Health
Cash	$673M	$300M
Debt	$278M	$0
Net Cash/Debt	$395M	$300M
Current Ratio (TTM)	3.04x	9.16x
Quick Ratio (TTM)	2.89x	8.60x
Debt/Equity (TTM)	0.23x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.57	2.00
52W Performance	-42.2%	28.9%
YTD Performance	-13.4%	6.7%
% from 52W High	-50.3%	-25.7%
% from 52W Low	14.7%	53.6%
Efficiency & Yields
Asset Turnover (TTM)	0.75x	0.39x
FCF Yield (TTM)	-3.4%	4.6%
Earnings Yield (TTM)	-2.5%	3.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	50.0	46.8
EV/GP/RG	0.13	0.60
Ticker research	View LEGN research	View VCYT research